Skip to main content

Table 1 Key molecular markers of each cell type in the TME

From: Technique integration of single-cell RNA sequencing with spatially resolved transcriptomics in the tumor microenvironment

Population

Subtypes

Marker

References

CAFs

–

α-SMA, vimentin, FAP, PDPN, PDGFRα/β, FSP1, DDR2, S100A4, CD10, GPR77

[36,37,38,39,40,41]

MSCs

–

CD105+, CD73+, CD70+, CD13+, CD29+, CD44+, CD10+, CD45−, CD34−, CD14− or CD11b−, CD79a−, HLA-DR−

[42,43,44]

TAMs

M1

CD68, CD11b, CD80, CD86

[45, 46]

M2

CD68, CD11b, CD163, CD206

DCs

cDC1

XCR1, CD45, CADM1, CLEC9A, CD141

[47, 48]

cDC2

CD45, CD1C, FcεR1A, CD172A

pDCs

CD45RA, CD123, CD2

Endothelial cells

–

PECAM1, CD31, CD34, CD13, CD29

[49, 50]

CD4+ T cells

–

CD3+CD4+CD8−

[51,52,53,54]

Th1 cells

CXCR3

Th2 cells

CCR4

Th17 cells

CCR6

Th22 cells

CCR10

Treg cells

CD4+CD25+Foxp3+

CD8+ T cells

-

CD3+ CD8+CD4−

Tc1 cells

CRCX3, IRF4

Tc2 cells

CCR4, CRTH2, GATA3

Tc9 cells

CRCX3, IRF4, IL9, IL10

Tc17 cells

CCR6, IL23R, IRF4, IL17

MDSCs

PMN-MDSCs

CD11b+CD33+HLA−DR−/CD14−CD15+

[55, 56]

M-MDSCs

CD11b+CD33+HLA−DR−/CD14+CD15−

  1. CAFs cancer-associated fibroblasts, MSCs mesenchymal stem cells, TAMs tumor-associated macrophages, DCs dendritic cells, cDCs conventional DCs, pDCs plasmacytoid DCs, MDSCs myeloid-derived suppressor cells, PMN-MDSCs granulocyte-like MDSCs, M-MDSCs monocytic MDSCs